Five percent to 9% of pancreatic ductal adenocarcinomas (PDACs) develop in patients with a germline BRCA1/2 or PALB2 (g BRCA/PALB2 +) mutation. Phase IB data from a trial that used cisplatin, ...

In this 13-week, multicenter, randomized trial, adults and children with type 1 diabetes who had been randomly assigned to automated glycemic control with a bionic pancreas had lower glycated ...

We conducted a multicenter risk-adapted study of DA-EPOCH-R in untreated adult Burkitt lymphoma. Low-risk patients received three cycles without CNS prophylaxis, and high-risk patients received six ...

The multicenter study is led by National Principal Investigator Dr. Aravinda Nanjundappa, MD, an Interventional Cardiologist at the Cleveland Clinic in Cleveland, Ohio. The first patient procedure ...